Sensus Healthcare to Present at Two Investment Conferences in March

Rhea-AI Summary

Sensus Healthcare (Nasdaq: SRTS), a medical device company, is set to present at two investment conferences in March 2022. The 34th Annual ROTH Conference will be held from March 13-15, with a key ‘Fireside Chat’ on March 15 at 9:30 a.m. PT. Investors can access the chat and a pre-recorded presentation on the company's website. Additionally, Sensus will participate in the Maxim 2022 Virtual Growth Conference on March 28-29, joining an Aesthetic Device Industry Panel on March 28 from 1:00 p.m. to 2:30 p.m. ET.

BOCA RATON, Fla. , March 09, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will be presenting at the following investment conferences during March:

• 34^th Annual ROTH Conference, March 13-15 at The Ritz-Carlton, Laguna Niguel. Management will be available for one-on-one meetings throughout the conference, both live and virtual. In addition, management will participate in a “Fireside Chat” on Tuesday, March 15^th from 9:30 a.m. to 9:55 a.m. PT.  Investors may listen to the “Fireside Chat” by clicking this link, which will also be posted in the Investors section of the Company’s website.  In addition, a pre-recorded company presentation will be available here and in the Investors section of the Company’s website.

• Maxim 2022 Virtual Growth Conference, March 28-29. Management will participate in the Aesthetic Device Industry Panel on Monday, March 28^th from 1:00 p.m. to 2:30 p.m. ET.  Investors may register for the conference and watch the panel here.

About Sensus Healthcare

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions. Sensus offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.

For more information, visit www.sensushealthcare.com.

Contact:
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
kgolodetz@lhai.com

#   #   #

FAQ

What investment conferences is SRTS participating in during March 2022?

Sensus Healthcare (SRTS) will present at the 34th Annual ROTH Conference from March 13-15 and the Maxim 2022 Virtual Growth Conference on March 28-29.

When will the 'Fireside Chat' for SRTS take place?

The 'Fireside Chat' for Sensus Healthcare (SRTS) is scheduled for March 15, 2022, from 9:30 a.m. to 9:55 a.m. PT.

How can investors access SRTS's presentations at the conferences?

Investors can listen to SRTS's 'Fireside Chat' via a link on the company's website and access a pre-recorded company presentation also available online.

What is Sensus Healthcare known for?

Sensus Healthcare (SRTS) specializes in non-invasive and minimally-invasive medical devices for treating oncological and non-oncological conditions.

What panel will SRTS be part of at the Maxim 2022 Virtual Growth Conference?

Sensus Healthcare (SRTS) will participate in the Aesthetic Device Industry Panel on March 28, 2022, from 1:00 p.m. to 2:30 p.m. ET.